Recognition with Seals of Excellence and Granting of the European R&D Project of the SME-1 program, to carry out the MyoDM clinical trials.

Myogem Health Company S.L. and its project “New food for special medical purposes for the nutritional treatment of myotonic dystrophy type 1” have received two Seals of Excellence and funding from the European Commission under the Phase 1 research program of the Horizon 2020 SME Instrument to carry out the clinical trial of the MYODM food supplement. The trial will be conducted at Donostia University Hospital, Biodonostia Institute.

View report

MyoDM, a breakthrough in the treatment of Steinert's Myotonic Dystrophy. Research and innovation at the service of your well-being.
Buy now

¿Do you have any questions
or need more information?

Fill out the form and our team will respond as soon as possible.
Email *
Subject *
Message *

Related news.

Scientific article with a complete overview through 2022 of the most recent drug development programs undergoing preclinical and clinical evaluation.

View report
Ver más

Doctoral thesis

Highest qualification awarded by the Thesis Committee: Dr. Rafael Mañez Mendiluce**, Dr. Carmen Escolano Mirón***, Arturo López Castel****
Ver más

Scientific article compiling the most recent drug development projects currently in the preclinical and clinical phases

View report
Ver más